Ledger.Open graph →
SEC Form D · filed December 20, 2023

Eterna Therapeutics Inc

Offering
$9.2M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Matthew Angel · Cambridge, MAExecDorothy Clarke · Cambridge, MADirectorWilliam Wexler · Cambridge, MADirectorSandra Gurrola · Cambridge, MAExecJames Bristol · Cambridge, MADirectorAndrew A. Tisdale · Providence, RIExecPhilippe Schulligen · Duluth, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗